M. Robuschi

1.6k total citations
43 papers, 1.2k citations indexed

About

M. Robuschi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, M. Robuschi has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Physiology, 31 papers in Pulmonary and Respiratory Medicine and 13 papers in Pharmacology. Recurrent topics in M. Robuschi's work include Asthma and respiratory diseases (35 papers), Inhalation and Respiratory Drug Delivery (19 papers) and Respiratory and Cough-Related Research (16 papers). M. Robuschi is often cited by papers focused on Asthma and respiratory diseases (35 papers), Inhalation and Respiratory Drug Delivery (19 papers) and Respiratory and Cough-Related Research (16 papers). M. Robuschi collaborates with scholars based in Italy, Switzerland and United States. M. Robuschi's co-authors include S. Bianco, Adriano Vaghi, G. Gambaro, Piersante Sestini, Maria Pieroni, Rosa Metella Refini, Angelo Sala, Giuseppe Mancia, Anna Monzani and Raffaella Dell’Oro and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.

In The Last Decade

M. Robuschi

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Robuschi Italy 17 883 613 339 138 104 43 1.2k
S. Bianco Italy 22 1.2k 1.4× 994 1.6× 392 1.2× 54 0.4× 154 1.5× 62 1.7k
Sarah E. Chesrown United States 19 422 0.5× 365 0.6× 57 0.2× 56 0.4× 86 0.8× 36 899
F.R. House United Kingdom 12 196 0.2× 232 0.4× 50 0.1× 66 0.5× 20 0.2× 13 893
F. Javier Salazar Spain 23 633 0.7× 155 0.3× 185 0.5× 607 4.4× 7 0.1× 86 1.7k
R. S. McNeill United Kingdom 14 456 0.5× 424 0.7× 38 0.1× 151 1.1× 38 0.4× 20 871
E Gramiccioni Italy 10 608 0.7× 466 0.8× 30 0.1× 35 0.3× 15 0.1× 13 906
C. Davis Canada 11 257 0.3× 188 0.3× 31 0.1× 87 0.6× 28 0.3× 21 576
María Aparecida Oliveira Brazil 16 188 0.2× 80 0.1× 97 0.3× 201 1.5× 15 0.1× 42 874
G. Unge Sweden 18 252 0.3× 106 0.2× 47 0.1× 181 1.3× 27 0.3× 47 761
Alessandra Adami Italy 19 240 0.3× 108 0.2× 85 0.3× 237 1.7× 10 0.1× 65 820

Countries citing papers authored by M. Robuschi

Since Specialization
Citations

This map shows the geographic impact of M. Robuschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Robuschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Robuschi more than expected).

Fields of papers citing papers by M. Robuschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Robuschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Robuschi. The network helps show where M. Robuschi may publish in the future.

Co-authorship network of co-authors of M. Robuschi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Robuschi. A scholar is included among the top collaborators of M. Robuschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Robuschi. M. Robuschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giannattasio, Cristina, et al.. (2007). Effects of prostaglandin E1α cyclodestrin treatment on endothelial dysfunction in patients with systemic sclerosis. Journal of Hypertension. 25(4). 793–797. 9 indexed citations
2.
Sestini, Piersante, Rosa Metella Refini, Maria Pieroni, et al.. (1999). Different Effects of Inhaled Aspirinlike Drugs on Allergen-Induced Early and Late Asthmatic Responses. American Journal of Respiratory and Critical Care Medicine. 159(4). 1228–1233. 11 indexed citations
3.
Robuschi, M., G. Gambaro, Piersante Sestini, et al.. (1997). Attenuation of Aspirin-Induced Bronchoconstriction by Sodium Cromoglycate and Nedocromil Sodium. American Journal of Respiratory and Critical Care Medicine. 155(4). 1461–1464. 21 indexed citations
4.
Sestini, Piersante, et al.. (1997). Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions☆☆☆★. Journal of Allergy and Clinical Immunology. 100(1). 71–77. 9 indexed citations
5.
Sestini, Piersante, G. Gambaro, Maria Pieroni, et al.. (1996). Inhaled PGE2 Prevents Aspirin-Induced Bronchoconstriction and Urinary LTE4 Excretion in Aspirin-Sensitive Asthma. American Journal of Respiratory and Critical Care Medicine. 153(2). 572–575. 198 indexed citations
6.
Bianco, S., et al.. (1995). Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone–dependent asthma. Journal of Allergy and Clinical Immunology. 95(5). 937–943. 20 indexed citations
7.
Bianco, S., Maria Pieroni, Rosa Metella Refini, et al.. (1994). Could NSAIDs Have a Role as Antiasthmatic Agents?. Drugs. 48(1). 9–15. 9 indexed citations
8.
Sestini, Piersante, et al.. (1994). Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics. European Respiratory Journal. 7(10). 1825–1829. 9 indexed citations
9.
Bianco, S., Adriano Vaghi, Maria Pieroni, et al.. (1993). Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate. Allergy. 48(8). 570–575. 15 indexed citations
10.
Bianco, S., M. Robuschi, Mario Scuri, et al.. (1993). Efficacy and Tolerability of Nimesulide in Asthmatic Patients Intolerant to Aspirin. Drugs. 46(Supplement 1). 115–120. 48 indexed citations
11.
Robuschi, M., Enrica Riva, L. M. Fuccella, et al.. (1992). Prevention of Exercise-induced Bronchoconstriction by a New Leukotriene Antagonist (SK&F 104353): A Double-Blind Study Versus Disodium Cromoglycate and Placebo. American Review of Respiratory Disease. 145(6). 1285–1288. 82 indexed citations
12.
Berti, F., et al.. (1992). Protective activity of inhaled frusemide against immunological respiratory changes and mediator release in guinea-pigs. Pulmonary Pharmacology. 5(2). 115–120. 4 indexed citations
13.
Berti, Ferruccio, et al.. (1991). Nimesulide, a Nonsteroidal Anti-Inflammatory Drug, Displays Antianaphylactic and Antihistaminic Activity in Guinea-Pigs. Clinical Drug Investigation. 3(S2). 39–47. 7 indexed citations
14.
Bianco, S., et al.. (1991). Bronchial Inflammation and NSAIDs. Clinical Drug Investigation. 3(S2). 33–38. 9 indexed citations
15.
Robuschi, M., Maria Pieroni, S. Bianco, et al.. (1990). Prevention of antigen-induced early obstructive reaction by inhaled furosemide in (atopic) subjects with asthma and (actively sensitized) guinea pigs. Journal of Allergy and Clinical Immunology. 85(1). 10–16. 27 indexed citations
16.
Berti, F., et al.. (1990). Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig.. PubMed. 40(9). 1011–6. 23 indexed citations
17.
Robuschi, M., et al.. (1989). Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction. Pulmonary Pharmacology. 1(4). 187–191. 79 indexed citations
18.
Robuschi, M.. (1988). Control of the Bronchial Tone. Respiration. 54(1). 100–107. 8 indexed citations
19.
Bianco, S., et al.. (1988). PREVENTION OF EXERCISE-INDUCED BRONCHOCONSTRICTION BY INHALED FRUSEMIDE. The Lancet. 332(8605). 252–255. 183 indexed citations
20.
Szczeklik, A, S. Bianco, M Schmitz-Schumann, et al.. (1988). Intolerance to Tartrazine in Aspirin-Induced Asthma: Results of a Multicenter Study. Respiration. 53(1). 20–23. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026